Thomas Krogh
Chief Operating Officer at VERITAS FARMS, INC.
Thomas Krogh active positions
| Companies | Position | Start | End |
|---|---|---|---|
| VERITAS FARMS, INC. | Chief Operating Officer | 24/08/2023 | - |
| Corporate Officer/Principal | 31/12/2019 | 24/08/2023 |
Career history of Thomas Krogh
Former positions of Thomas Krogh
| Companies | Position | Start | End |
|---|---|---|---|
CBR International Corp.
 CBR International Corp. Miscellaneous Commercial ServicesCommercial Services Part of Novotech Holdings Pty Ltd., Novotech Drug Development Consulting (formerly CBR International Corp.) is a full-service product development, clinical oversight, and regulatory operations group. The company is based in Boulder, CO. CBR International was acquired by Novotech Holdings Pty Ltd. on January 09, 2023. Novotech Drug Development Consulting provides comprehensive "lab to launch" program development services and is currently assisting companies with COVID-19 development programs and FDA's Coronavirus Treatment Acceleration Program (CTAP). The company was founded in 1999 by Jeanne M. Novak, who has been the CEO since 1999. | Corporate Officer/Principal | - | - |
Training of Thomas Krogh
| University of Denver | Undergraduate Degree |
Statistics
International
| United States | 4 |
Operational
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Consumer Services | 2 |
| Commercial Services | 2 |
| Process Industries | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| VERITAS FARMS, INC. | Process Industries |
| Private companies | 1 |
|---|---|
CBR International Corp.
CBR International Corp. Miscellaneous Commercial ServicesCommercial Services Part of Novotech Holdings Pty Ltd., Novotech Drug Development Consulting (formerly CBR International Corp.) is a full-service product development, clinical oversight, and regulatory operations group. The company is based in Boulder, CO. CBR International was acquired by Novotech Holdings Pty Ltd. on January 09, 2023. Novotech Drug Development Consulting provides comprehensive "lab to launch" program development services and is currently assisting companies with COVID-19 development programs and FDA's Coronavirus Treatment Acceleration Program (CTAP). The company was founded in 1999 by Jeanne M. Novak, who has been the CEO since 1999. | Commercial Services |
- Stock Market
- Insiders
- Thomas Krogh
- Experience